Contact
Please use this form to send email to PR contact of this press release:
OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101
TO:
Please use this form to send email to PR contact of this press release:
OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101
TO: